Radiation therapy in Hodgkin disease: Why risk a Pyrrhic victory?

被引：18

作者：

Longo, DL ^{[1
]}

机构：

[1] NIA, Baltimore, MD 21224 USA

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2005年 / 97卷 / 19期

关键词：

D O I：

10.1093/jnci/dji310

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1394 / 1395

页数：2

共 10 条

[1] CANCER IN THE CONTRALATERAL BREAST AFTER RADIOTHERAPY FOR BREAST-CANCER [J].

BOICE, JD ;

HARVEY, EB ;

BLETTNER, M ;

STOVALL, M ;

FLANNERY, JT .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (12) :781-785

[2] RADIATION-DOSE AND BREAST-CANCER RISK IN PATIENTS TREATED FOR CANCER OF THE CERVIX [J].

BOICE, JD ;

BLETTNER, M ;

KLEINERMAN, RA ;

ENGHOLM, G ;

STOVALL, M ;

LISCO, H ;

AUSTIN, DF ;

BOSCH, A ;

HARLAN, L ;

KREMENTZ, ET ;

LATOURETTE, HB ;

MERRILL, JA ;

PETERS, LJ ;

SCHULZ, MD ;

WACTAWSKI, J ;

STORM, HH ;

BJORKHOLM, E ;

PETTERSSON, F ;

BELL, CMJ ;

COLEMAN, MP ;

FRASER, P ;

NEAL, FE ;

PRIOR, P ;

CHOI, NW ;

HISLOP, TG ;

KOCH, M ;

KREIGER, N ;

ROBB, D ;

ROBSON, D ;

THOMSON, DH ;

LOCHMULLER, H ;

VONFOURNIER, D ;

FRISCHKORN, R ;

KJORSTAD, KE ;

RIMPELA, A ;

PEJOVIC, MH ;

KIRN, VP ;

STANKUSOVA, H ;

PISANI, P ;

SIGURDSSON, K ;

HUTCHISON, GB ;

MACMAHON, B .

INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (01) :7-16

[3] Radiation and breast carcinogenesis [J].

Boice, JD .

MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 36 (05) :508-513

[4] Hormone replacement therapy and breast cancer: estimate of risk [J].

Coombs, NJ ;

Taylor, R ;

Wilcken, N ;

Boyages, J .

BMJ-BRITISH MEDICAL JOURNAL, 2005, 331 (7512) :347-349

[5] Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease [J].

Loeffler, M ;

Brosteanu, O ;

Hasenclever, D ;

Sextro, M ;

Assouline, D ;

Bartolucci, AA ;

Cassileth, PA ;

Crowther, D ;

Diehl, V ;

Fisher, RI ;

Hoppe, RT ;

Jacobs, P ;

Pater, JL ;

Pavlovsky, S ;

Thompson, E ;

Wiernik, P .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (03) :818-829

[6]

Preston DL, 2002, RADIAT RES, V158, P220, DOI 10.1667/0033-7587(2002)158[0220:REOBCR]2.0.CO

[7]

[8] Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease: A meta-analysis of 23 randomized trials involving 3,888 patients [J].

Specht, L ;

Gray, RG ;

Clarke, MJ ;

Peto, R .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (03) :830-843

[9] Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease [J].

Straus, DJ ;

Portlock, CS ;

Qin, J ;

Myers, J ;

Zelenetz, AD ;

Moskowitz, C ;

Noy, A ;

Goy, A ;

Yahalom, J .

BLOOD, 2004, 104 (12) :3483-3489

[10] Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma [J].

Travis, LB ;

Hill, D ;

Dores, GM ;

Gospodarowicz, M ;

van Leeuwen, FE ;

Holowaty, E ;

Glimelius, B ;

Andersson, M ;

Pukkala, E ;

Lynch, CF ;

Pee, D ;

Smith, SA ;

Van't Veer, MB ;

Joensuu, T ;

Storm, H ;

Stovall, M ;

Boice, JD ;

Gilbert, E ;

Gail, MH .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (19) :1428-1437

← 1 →